Latest filing published 12 Mar 2026 for Cytek Biosciences, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Valerie Barnett, listed as board member, appears in our data through filings on Cytek Biosciences, Inc. shares, published by SEC (Form 4). In total, 21 filings cover trades dated from 22 July 2021 to 10 March 2026.
Purchases make up the whole of the open-market record (1 purchase, €27k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 20 option exercises.
On 12 March 2026 came the latest disclosure, an option exercise in Cytek Biosciences, Inc. The clock since the last published purchase (27 July 2021) now reads 1,909 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations